Oxidative stress, aging, and diseases

I Liguori, G Russo, F Curcio, G Bulli, L Aran… - … interventions in aging, 2018 - Taylor & Francis
Reactive oxygen and nitrogen species (RONS) are produced by several endogenous and
exogenous processes, and their negative effects are neutralized by antioxidant defenses …

Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart

RJ Reiter, DX Tan - Cardiovascular research, 2003 - academic.oup.com
This brief review summarizes the recently obtained evidence which illustrates the beneficial
effects of the endogenously produced antioxidant, melatonin, in reducing tissue damage …

Melatonin: therapeutic and clinical utilization

A Altun, B Ugur‐Altun - International journal of clinical practice, 2007 - Wiley Online Library
Melatonin, acting through melatonin receptors, is involved in numerous physiological
processes including circadian entrainment, blood pressure regulation, oncogenesis, retinal …

Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders

M Laudon, A Frydman-Marom - International journal of molecular …, 2014 - mdpi.com
Several melatonin receptors agonists (ramelteon, prolonged-release melatonin,
agomelatine and tasimelteon) have recently become available for the treatment of insomnia …

[PDF][PDF] Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage

ÜK Kilic - Pol. J. Pharmacol, 2004 - if-pan.krakow.pl
This review briefly summarizes the actions of melatonin in reducing molecular damage
caused by free radicals and associated oxygen-and nitrogenbased reactants. All the …

Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening

G Petrosillo, G Colantuono, N Moro… - American journal …, 2009 - journals.physiology.org
Melatonin, a well-known antioxidant, has been shown to protect against ischemia-
reperfusion myocardial damage. Mitochondrial permeability transition pore (MPTP) opening …

[HTML][HTML] The therapeutic potential of melatonin: a review of the science

S Malhotra, G Sawhney, P Pandhi - Medscape General Medicine, 2004 - ncbi.nlm.nih.gov
Melatonin is a ubiquitous natural neurotransmitter-like compound produced primarily by the
pineal gland. This agent is involved in numerous aspects of the biological and physiologic …

Chronic melatonin consumption prevents obesity‐related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a …

F Nduhirabandi, EF Du Toit, D Blackhurst… - Journal of pineal …, 2011 - Wiley Online Library
Obesity, a major risk factor for ischemic heart disease, is associated with increased oxidative
stress and reduced antioxidant status. Melatonin, a potent free radical scavenger and …

Melatonin and the metabolic syndrome: a tool for effective therapy in obesity‐associated abnormalities?

F Nduhirabandi, EF du Toit, A Lochner - Acta physiologica, 2012 - Wiley Online Library
The metabolic syndrome (M et S) is a cluster of metabolic abnormalities associated with
increased risk for cardiovascular diseases. Apart from its powerful antioxidant properties, the …

Combined therapy with simvastatin and bone marrow–derived mesenchymal stem cells increases benefits in infarcted swine hearts

YJ Yang, HY Qian, J Huang, JJ Li, RL Gao… - … , and vascular biology, 2009 - Am Heart Assoc
Objective—Widespread death of implanted cells hampers stem cell therapy for acute
myocardial infarction (AMI). Based on the pleiotropic beneficial effects of statins, we …